Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medly Health was a U.S. digital pharmacy company that operated Medly Pharmacy, a full-service pharmacy platform offering same-day prescription delivery, insurance claim processing, refill management, and patient support services. The business combined software-enabled pharmacy operations with both digital fulfillment and, after its acquisition of Pharmaca, a brick-and-mortar retail footprint. Medly expanded rapidly during the COVID-19 era and raised substantial venture financing, but filed for Chapter 11 bankruptcy in December 2022 amid a liquidity crisis and accounting irregularities; its cases were converted to Chapter 7 in April 2023. The company is now defunct, and in September 2024 the SEC charged former executives with allegedly defrauding investors by overstating revenue and using fake prescriptions. Medly is healthcare-related, but it was not a therapeutics developer and did not have a drug pipeline in the biotech/pharma sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medly Health.